Barbara S. Schilberg
Director/Board Member at Jenrin Discovery LLC
Profile
Prior to joining BioAdvance, Ms. Schilberg developed years of experience in the biopharmaceutical industry.
Her experience in senior management started in 1994 when she joined Cephalon as Senior Vice President and General Counsel and as a member of the executive committee.
As part of her responsibilities, she led a multi-disciplinary team charged with completing Phase III clinical trials and preparing a new drug application for PROVIGIL, which was approved by the FDA in December 1999.
Ms. Schilberg joined Incara Pharmaceuticals in 1998 as Executive Vice President and General Counsel, where she managed a research operation in Princeton, NJ engaged in discovering new antibacterial therapeutics.
She also served as Vice President and General Counsel at Locus Discovery, Inc., an emerging pharmaceutical company in Blue Bell, PA engaged in computational drug design.
Before joining the industry, she specialized in representing biopharmaceutical companies and research institutions in the commercialization of technology.
Before joining industry, Ms. Schilberg specialized in representing biopharmaceutical companies and research institutions in the commercialization of technology, as a partner in the Philadelphia office of Morgan, Lewis & Bockius.
There she developed novel strategies for the licensing and commercialization of life sciences technology on behalf of biopharmaceutical companies such as Cephalon, Inc. and non-profit research institutions such as the University of Pennsylvania, The Wistar Institute and Thomas Jefferson University.
Her practice supported a wide range of industry activities, including venture capital financings, IPOs and other public offerings, marketing, co-development and joint-venture arrangements, sponsored research, and technology transfer.
Ms. Schilberg received her J.D.
from the University of Virginia and clerked with the Honorable Edward R.
Becker, now Senior Judge of the U.S.
Court of Appeals for the Third Circuit.
Barbara S. Schilberg active positions
| Companies | Position | Start |
|---|---|---|
Jenrin Discovery LLC
 Jenrin Discovery LLC Pharmaceuticals: MajorHealth Technology Jenrin Discovery, Inc. develops therapeutics for chronic diseases. It provides therapeutics for various diseases, including obesity, diabetes, and autoimmune and inflammatory disorders. The company was founded by John F. McLeroy on April 17, 2007 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Marillion Pharmaceuticals, Inc.
 Marillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marillion Pharmaceuticals, Inc. provides cancer pharmaceuticals. It focuses on the development and commercialization of novel therapeutics for the treatment of cancers and for care in oncology. The firm products include Lu-AMBA, Pilobuc, and MN-201. The company was founded by Jerry Glickson, Zahed Subhan, and Gang Zheng in February 2005 and is headquartered in Radnor, PA. | Director/Board Member | 10/01/2010 |
Mebias Discovery, LLC
 Mebias Discovery, LLC Pharmaceuticals: MajorHealth Technology Mebias Discovery, LLC engages in discovering drugs. The company was founded by Lawrence C. Kuo, Brett A. Tounge and Shariff S. Bayoumy in January 2016 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Former positions of Barbara S. Schilberg
| Companies | Position | End |
|---|---|---|
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Chief Executive Officer | 29/09/2021 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 30/12/1997 |
| ANNOVIS BIO, INC. | Director/Board Member | - |
PhenoTech, Inc.
 PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Director/Board Member | - |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Corporate Officer/Principal | - |
Training of Barbara S. Schilberg
| University of Virginia | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ANNOVIS BIO, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
| Incara Pharmaceuticals Corp. | Health Technology |
Jenrin Discovery LLC
Jenrin Discovery LLC Pharmaceuticals: MajorHealth Technology Jenrin Discovery, Inc. develops therapeutics for chronic diseases. It provides therapeutics for various diseases, including obesity, diabetes, and autoimmune and inflammatory disorders. The company was founded by John F. McLeroy on April 17, 2007 and is headquartered in Philadelphia, PA. | Health Technology |
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
The Biotechnology Greenhouse Corp. of Southeastern PA
The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Marillion Pharmaceuticals, Inc.
Marillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Marillion Pharmaceuticals, Inc. provides cancer pharmaceuticals. It focuses on the development and commercialization of novel therapeutics for the treatment of cancers and for care in oncology. The firm products include Lu-AMBA, Pilobuc, and MN-201. The company was founded by Jerry Glickson, Zahed Subhan, and Gang Zheng in February 2005 and is headquartered in Radnor, PA. | Health Technology |
PhenoTech, Inc.
PhenoTech, Inc. BiotechnologyHealth Technology PhenoTech, Inc. develops and markets monoclonal antibodies which are used in blood diagnostic and therapeutic applications. It offers blood diagnostic reagents, such as nanoscale emissive antibody-complexes for typing reagents for pre-transfusion testing. The company was founded by Eric Ostertag in 2003 and is headquartered in Philadelphia, PA. | Health Technology |
Mebias Discovery, LLC
Mebias Discovery, LLC Pharmaceuticals: MajorHealth Technology Mebias Discovery, LLC engages in discovering drugs. The company was founded by Lawrence C. Kuo, Brett A. Tounge and Shariff S. Bayoumy in January 2016 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Barbara S. Schilberg
